Feladilimab - Research Grade Biosimilar, CAS [[2252518-85-5]], Unconjugated, Monoclonal
Artikelnummer:
PRS-21-913
Artikelname: |
Feladilimab - Research Grade Biosimilar, CAS [[2252518-85-5]], Unconjugated, Monoclonal |
Artikelnummer: |
PRS-21-913 |
Hersteller Artikelnummer: |
21-913 |
Alternativnummer: |
PRS-21-913-0.1 |
Hersteller: |
ProSci |
Kategorie: |
Antikörper |
Immunogen: |
Humanized / ICOS |
Konjugation: |
Unconjugated |
Alternative Synonym: |
ANTI-ICOS AGONIST ANTIBODY GSK3359609, FELADILIMAB, FELADILIMAB [INN], FELADILIMAB [USAN], GSK 3359609 [WHO-DD], GSK3359609, GSK-3359609, GSK-609, IMMUNOGLOBULIN G4 (229-PROLINE,236-GLUTAMIC ACID), ANTI-(HUMAN INDUCIBLE T-CELL CO-STIMULATOR (ICOS)) (HUMA |
Klonalität: |
Monoclonal |
Konzentration: |
batch dependent |
NCBI: |
29851 |
UniProt: |
Q9Y6W8 |
Puffer: |
PBS buffer pH 7.5 |
Quelle: |
CHO cells |
Reinheit: |
>95% |
CAS Nummer: |
[2252518-85-5] |
Application Verdünnung: |
For research use only . |